Insider Trading History of Cho Michael

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Cho Michael since 2007. The trader's CIK number is 1300949. At the time of the last reporting, Cho Michael was the 10% Owner of Xtl Biopharmaceuticals Ltd. (stock ticker symbol XTLB). Also see all insider trading activities at Xtl Biopharmaceuticals Ltd.

Note that in the past Cho Michael also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Macrochem Corp (MACM.OB) by Cho Michael

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 MACM.OB 100,000 $86,000 100,000 $38,000 0 $0

Yearly summary of insider trading at Xtl Biopharmaceuticals Ltd (XTLB) by Cho Michael

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 XTLB 908,610 $3,056,449 0 $0 0 $0


Insider trading activities at 2 companies by Cho Michael:

1. Macrochem Corp (MACM.OB)

2. Xtl Biopharmaceuticals Ltd (XTLB)

Table 1. Insider trading of Macrochem Corp (MACM.OB) by Cho Michael

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-12-18 MACM.OB Sale 100,000 .38 38,000
2007-11-06 MACM.OB Buy 100,000 .86 86,000

Table 2. Insider trading of Xtl Biopharmaceuticals Ltd (XTLB) by Cho Michael

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-04-30 XTLB Buy 128,370 3.74 480,488
2008-04-29 XTLB Buy 229,240 3.54 810,821
2008-04-10 XTLB Buy 100,000 3.57 356,700
2008-02-20 XTLB Buy 1,000 3.84 3,840
2008-01-03 XTLB Buy 250,000 3.10 775,000
2005-01-04 XTLB Buy 188,000 3.15 591,824
2008-01-04 XTLB Buy 12,000 3.15 37,776

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cho Michael (10% Owner of Xtl Biopharmaceuticals Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.